Evidence for cPLA2 activation in Alzheimer's Disease Synaptic Pathology

Keyphrases

• Phospholipase A2 (PLA2) 100%
• Alzheimer's Disease 100%
• Calcium-dependent 100%
• Alzheime's Disease 100%
• Synaptic Pathology 100%
• Synaptosomes 31%
• Postsynaptic Density Protein 95 (PSD-95) 21%
• Synaptic Dysfunction 21%
• Eicosanoids 15%
• Cognitive Decline 15%
• Microtubule-associated Protein 2 (MAP2) 15%
• Neurodegeneration 10%
• Neuronal Soma 10%
• Synapse 10%
• No Cognitive Impairment 10%
• Phospholipase A2 Inhibitor 10%
• Overactivation 10%
• Neuritic Plaques 10%
• IPSC-derived Neurons 10%
• Synaptic Markers 10%
• Cognitive Impairment Diseases 10%
• Molecular Mechanism 5%
• Alzheimer's Disease Brain 5%
• Synaptic 5%
• Frontal Cortex 5%
• Arachidonic Acid 5%
• Amyloid Pathology 5%
• New Targets 5%
• Disease-modifying Therapy 5%
• Cognitive Dysfunction 5%
• Spontaneous Excitatory Postsynaptic Current (sEPSC) 5%
• Neuroinflammation 5%
• Immunofluorescent Staining 5%
• CaMKII 5%
• Cytosolic Phospholipase A2 (cPLA2) 5%
• Mild Cognitive Impairment 5%
• Soma 5%
• Phospholipase A2 Activity 5%
• Lipidomics 5%
• Membrane Phospholipids 5%
• Ca2+/calmodulin-dependent Protein Kinase II 5%
• Future Research Needs 5%
• Tau Pathology 5%
• Alzheimer's Disease Dementia 5%
• Excitotoxicity 5%
• Religious Orders Study 5%
• Cytosol 5%
• Catalytic Membrane 5%
• Dendrodendritic Synapses 5%

Neuroscience

• Phospholipase A2 100%
• Alzheimer's Disease 100%
• Synaptosome 31%
• Amyloid Protein 21%
• Disks Large Homolog 4 21%
• Postsynaptic Density Protein 95 21%
• Synaptic Loss 21%
• Eicosanoid 15%
• Cognitive Disorders 15%
• Synapse 15%
• Oligomer 15%
• Microtubule Associated Protein 2 15%
• Cognitive Decline 15%
• Neurodegeneration 10%
• Soma 10%
• Senile Plaque 10%
• Calcium Calmodulin Dependent Protein Kinase II 10%
• Carisoprodol 10%
• Arachidonic Acid 5%
• Staining Technique 5%
• Frontal Lobe 5%
• Dendrite 5%
• Mild Cognitive Impairment 5%
• Excitotoxicity 5%
• Cytosolic Phospholipase A2 5%
• Membrane Phospholipid 5%
• Catalysis 5%